Platform
Features
0 followers
GABA Therapeutics is developing GRX-917 for anxiety and depression, with fast onset, minimal side effects and is non-addictive.
Industries
Headquarters
Employees
Links
5 members
3 members
This company has no offices yet
Tessera Therapeutics
2 followers
Vaxcyte
Arcellx
1 follower
Thermo Fisher Scientific
173 followers
Gilead Sciences
133 followers
Biogen
119 followers
Alexion Pharmaceuticals
34 followers
10X Genomics
13 followers
Avantor
10 followers
Amyris
9 followers
Sarepta Therapeutics
Explore companies